Private Advisor Group, LLC

Holdings History for AN2 Therapeutics, Inc. - Common Stock, par value $0.00001 per share (ANTX)

Symbol: ANTX on Nasdaq
Investment type: Equity / Common Stock, par value $0.00001 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0%	0%	$25,650	22,500	0		$1.14	Q4 2025
30 Sep 2025	0%	0%	$28,575	22,500	0		$1.27	Q3 2025
30 Jun 2025	0%	0%	$23,850	22,500	0		$1.06	Q2 2025
31 Mar 2025	0%	0%	$30,600	22,500	0		$1.36	Q1 2025
31 Dec 2024	0%	0%	$31,050	22,500	0		$1.38	Q4 2024
30 Sep 2024	0%	0%	$24,075	22,500	0		$1.07	Q3 2024
30 Jun 2024	0%	0%	$48,375	22,500	0		$2.15	Q2 2024
31 Mar 2024	0%	+0%	$73,125	22,500	+22,500	NEW	$3.25	Q1 2024
30 Sep 2023		-0%	$0	0	-67,500	-100%	$1.32	Q3 2023
30 Jun 2023	0%	+0%	$573,751	67,500	+45,492	+207%	$8.50	Q2 2023
31 Mar 2023	0%	+0%	$217,219	22,008	+11,000	+100%	$9.87	Q1 2023
31 Dec 2022	0%	0%	$105,000	11,008	0		$9.54	Q4 2022
30 Sep 2022		-0%	$0	0	-11,001	-100%	$1.32	Q3 2022
30 Jun 2022	0%	+0%	$165,000	11,001	+11,001	NEW	$15.00	Q2 2022

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.